Iovance Biotherapeutics (IOVA) Q4 2023 Earnings

28FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.8
-0.68
-0.55
-0.43

Details

Expected EPS
-0.430785
Actual EPS
-0.45
Surprise EPS
-0.02
Surprise Percent
+4.46%

Description

Iovance Biotherapeutics (IOVA) has reported earnings of -0.45 per share for Q4 2023.

0 Comments

Share your thoughts